Back to Search Start Over

High serum soluble CD155 level predicts poor prognosis and correlates with an immunosuppressive tumor microenvironment in hepatocellular carcinoma

High serum soluble CD155 level predicts poor prognosis and correlates with an immunosuppressive tumor microenvironment in hepatocellular carcinoma

Authors :
An‐Li Jin
Yi‐Hui Yang
Xi Su
Wen‐Jing Yang
Te Liu
Wei Chen
Tong Li
Lin Ding
Hao Wang
Bei‐Li Wang
Bai‐Shen Pan
Jian Zhou
Jia Fan
Xin‐Rong Yang
Wei Guo
Source :
Journal of Clinical Laboratory Analysis. 36
Publication Year :
2022
Publisher :
Wiley, 2022.

Abstract

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies with poor prognosis. There is no research about the clinical significance of serum soluble CD155 (sCD155) level for HCC. We aim to explore the prognostic and diagnostic value of sCD155 in HCC patients undergoing curative resection.Serum sCD155 level in HCC patients was determined by enzyme-linked immunosorbent assay. The prognostic significance of sCD155 was evaluated by Cox regression and Kaplan-Meier analyses. CD155 expression and biomarkers of immune cells in HCC tissues were detected by immunohistochemistry staining. The diagnostic significance of sCD155 was evaluated using receiver operating characteristic curve.Serum sCD155 level was significantly increased in HCC patients and predicted poor prognosis. The prognostic value of sCD155 remained in low recurrent risk subgroups of HCC. Serum sCD155 level was positively related to CD155 expression in HCC tissues. High serum sCD155 level was associated with decreased numbers of CD8Serum sCD155 level represents a promising biomarker for diagnosis and prognosis of HCC. High serum sCD155 level may reflect an immunosuppressive tumor microenvironment in HCC.

Details

ISSN :
10982825 and 08878013
Volume :
36
Database :
OpenAIRE
Journal :
Journal of Clinical Laboratory Analysis
Accession number :
edsair.doi.dedup.....0003344205976a116ecb09ef81a8f86a
Full Text :
https://doi.org/10.1002/jcla.24259